Chapter
Elon Musk's Engineering Prowess Could Help COVID-19 Situation
1:01:26 - 1:09:27 (08:00)
A podcast speaker suggests that physicians may not be the most qualified people to make decisions about public health, including the COVID-19 pandemic. Instead, he suggests that engineers like Elon Musk could make a significant impact with the ability to create rapid COVID-19 tests in the tens of millions per day.
Clips
In this podcast, the speaker proposes the solution of deploying rapid COVID-19 tests to everybody in order to open up the economy in April.
1:01:26 - 1:02:51 (01:24)
Summary
In this podcast, the speaker proposes the solution of deploying rapid COVID-19 tests to everybody in order to open up the economy in April. He suggests that someone like Elon Musk could build these machines at a very large scale and get society open, and the return on investment for him would be significant.
ChapterElon Musk's Engineering Prowess Could Help COVID-19 Situation
Episode#146 – Michael Mina: Rapid Testing, Viruses, and the Engineering Mindset
PodcastLex Fridman Podcast
A call for rapid tests to be released as soon as possible to help combat the pandemic, with a plea for engineers to lead the charge instead of physicians, so that the public health program can be maximised for effectiveness.
1:02:51 - 1:08:16 (05:25)
Summary
A call for rapid tests to be released as soon as possible to help combat the pandemic, with a plea for engineers to lead the charge instead of physicians, so that the public health program can be maximised for effectiveness.
ChapterElon Musk's Engineering Prowess Could Help COVID-19 Situation
Episode#146 – Michael Mina: Rapid Testing, Viruses, and the Engineering Mindset
PodcastLex Fridman Podcast
The COVID-19 pandemic has presented us with new challenges, but we could save millions of lives by embracing innovation.
1:08:16 - 1:09:27 (01:11)
Summary
The COVID-19 pandemic has presented us with new challenges, but we could save millions of lives by embracing innovation. Unfortunately, the government agency responsible for drug approval, the FDA, has been slow to accept and license new treatments and tests.